NASDAQ:ENTX
Entera Bio Ltd.
- Stock
Last Close
3.11
06/11 21:00
Market Cap
64.47M
Beta: 1.84
Volume Today
13.71K
Avg: 246.50K
PE Ratio
−3.78
PFCF: −3.20
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 65K - | 103K 58.46% | -8.50K 108.25% | -46.50K 447.06% | -147K 216.13% | -147K 0% | ||||
average payables | 202K - | 324.50K 60.64% | 534.50K 64.71% | 403.50K 24.51% | 1.09M 169.52% | 1.00M 7.72% | 753.50K 24.91% | 712K 5.51% | ||
average receivables | 362.50K - | 501.50K 38.34% | 397K 20.84% | 349.50K 11.96% | 361.50K 3.43% | 270K 25.31% | ||||
book value per share | -2.16 - | -2.94 36.39% | -3.68 25.00% | 1.27 134.55% | 0.98 22.83% | 0.36 63.12% | 0.86 138.59% | 0.41 52.75% | 0.36 12.25% | |
capex per share | -0.00 - | -0.00 5.36% | -0.01 24.39% | -0.01 43.69% | -0.00 61.47% | -0.00 12.61% | -0.00 77.40% | -0.00 150.81% | -0.00 64.08% | |
capex to depreciation | -1.93 - | -1.17 39.26% | -1.19 1.25% | -1.26 6.17% | -0.17 86.65% | -0.24 40.16% | -0.32 36.17% | -0.73 128.95% | -0.30 58.66% | |
capex to operating cash flow | 0.02 - | 0.01 15.54% | 0.01 13.65% | 0.01 38.40% | 0.00 35.39% | 0.01 13.38% | 0.00 63.11% | 0.00 100.47% | 0.00 38.15% | |
capex to revenue | -0.14 - | -0.17 24.63% | -0.15 14.33% | -0.03 79.50% | -0.35 1,078.09% | |||||
cash per share | 0.10 - | 0.49 379.42% | 1.37 182.15% | 1.45 5.70% | 1.25 13.68% | 0.47 62.68% | 0.95 104.14% | 0.43 55.14% | 0.38 11.10% | |
days of inventory on hand | 132.10 - | -162.42 222.95% | -1.06K - | |||||||
days payables outstanding | 580.52 - | 3.22K 453.83% | 162.44 94.95% | 4.85K 2,883.38% | 540.98 88.84% | |||||
days sales outstanding | 529.25 - | 429.96 18.76% | 516 20.01% | 116.98 77.33% | 1.47K 1,157.40% | |||||
debt to assets | 2.93 - | 2.34 20.12% | 0.29 87.48% | 0.02 - | 0.04 135.17% | 0.01 72.39% | 0.01 40.35% | 0.03 378.19% | ||
debt to equity | -0.31 - | -0.58 85.98% | -0.12 78.84% | 0.03 - | 0.06 158.38% | 0.01 79.35% | 0.01 42.15% | 0.04 385.02% | ||
dividend yield | ||||||||||
earnings yield | -0.06 - | -0.02 61.14% | -0.21 833.86% | -0.42 104.20% | -0.42 1.45% | -0.50 19.92% | -0.17 67.05% | -0.62 275.86% | -0.51 17.83% | |
enterprise value | 81.56M - | 64.40M 21.04% | 45.99M 28.59% | 16.76M 63.56% | 11.11M 33.72% | 11.73M 5.59% | 49.11M 318.67% | 8.81M 82.06% | 6.78M 23.11% | |
enterprise value over ebitda | -22.21 - | -12.08 45.61% | -4.02 66.73% | -1.55 61.41% | -0.99 36.13% | -1.05 6.38% | -4.04 283.18% | -0.68 83.23% | -0.76 12.66% | |
ev to operating cash flow | -23.34 - | -20.50 12.17% | -10.16 50.42% | -1.71 83.16% | -1.25 27.20% | -1.13 9.64% | -5.42 381.49% | -0.71 86.99% | -0.93 31.47% | |
ev to sales | 33.52 - | 47.07 40.43% | 32.14 31.73% | 86.00 167.62% | 65.76 23.54% | |||||
free cash flow per share | -0.30 - | -0.37 24.46% | -0.53 43.80% | -1.24 132.25% | -0.74 40.51% | -0.57 22.88% | -0.35 38.92% | -0.44 25.35% | -0.25 42.00% | |
free cash flow yield | -0.05 - | -0.06 24.46% | -0.09 43.80% | -0.41 378.21% | -0.34 15.22% | -0.53 52.81% | -0.12 76.61% | -0.60 384.21% | -0.42 29.43% | |
graham net net | -2.29 - | -3.19 39.48% | -3.86 20.90% | 1.12 129.00% | 0.88 21.69% | 0.29 66.94% | 0.83 185.34% | 0.39 53.00% | 0.33 14.48% | |
graham number | 4.18 - | 3.04 27.20% | 10.40 241.66% | 6.09 41.47% | 4.45 26.95% | 2.10 52.76% | 3.01 43.27% | 2.04 32.19% | 1.57 23.02% | |
income quality | 0.82 - | 2.62 221.06% | 0.40 84.57% | 0.95 135.20% | 0.83 13.09% | 1.04 26.37% | 0.74 28.77% | 0.96 28.59% | 0.82 14.00% | |
intangibles to total assets | 0.24 - | 0.10 56.30% | 0.05 52.66% | 0.05 0.93% | 0.04 25.77% | 0.06 62.77% | 0 100% | 0 | 0 | |
interest coverage | -421.28 - | 0.50 100.12% | ||||||||
interest debt per share | 0.68 - | 1.72 153.66% | 0.45 73.55% | 0.02 - | 0.02 4.71% | 0.01 46.00% | -0.90 7,201.40% | 0.01 101.49% | ||
inventory turnover | 2.76 - | -2.25 181.33% | -0.34 - | |||||||
invested capital | -0.31 - | -0.58 85.98% | -0.12 78.84% | 0.03 - | 0.06 158.38% | 0.01 79.35% | 0.01 42.15% | 0.04 385.02% | ||
market cap | 74.71M - | 53.84M 27.94% | 53.84M 0% | 24.26M 54.93% | 25.99M 7.13% | 19.89M 23.48% | 73.70M 270.52% | 21.03M 71.46% | 17.40M 17.24% | |
net current asset value | -26.53M - | -26.10M 1.64% | -32.42M 24.22% | 9.24M 128.50% | 10.85M 17.43% | 5.51M 49.21% | 21.91M 297.44% | 11.48M 47.61% | 9.88M 13.92% | |
net debt to ebitda | -1.86 - | -1.98 6.20% | 0.69 134.65% | 0.69 1.23% | 1.33 91.09% | 0.73 44.77% | 2.02 175.77% | 0.94 53.57% | 1.20 27.47% | |
net income per share | -0.36 - | -0.14 61.14% | -1.31 833.86% | -1.30 0.83% | -0.90 30.85% | -0.54 39.48% | -0.47 13.97% | -0.45 2.70% | -0.31 32.46% | |
operating cash flow per share | -0.29 - | -0.37 24.75% | -0.53 44.05% | -1.23 133.25% | -0.73 40.37% | -0.57 22.92% | -0.35 38.72% | -0.43 25.11% | -0.25 41.92% | |
payables turnover | 0.63 - | 0.11 81.94% | 2.25 1,879.28% | 0.08 96.65% | 0.67 795.81% | |||||
receivables turnover | 0.69 - | 0.85 23.09% | 0.71 16.67% | 3.12 341.10% | 0.25 92.05% | |||||
research and ddevelopement to revenue | 17.04 - | 30.50 79.06% | 17.53 42.54% | 11.86 32.35% | 43.64 268.03% | |||||
return on tangible assets | -2.05 - | -0.21 89.59% | -0.89 316.63% | -0.81 8.45% | -0.68 16.77% | -1.03 52.97% | -0.47 54.63% | -1.00 112.33% | -0.76 24.12% | |
revenue per share | 0.06 - | 0.02 69.09% | 0.02 2.00% | 0.02 10.25% | 0.00 78.71% | |||||
roe | 0.17 - | 0.05 71.51% | 0.35 647.08% | -1.02 387.08% | -0.91 10.39% | -1.50 64.10% | -0.54 63.94% | -1.11 105.90% | -0.86 23.04% | |
roic | 0.21 - | 0.51 142.94% | -0.40 179.36% | -1.13 179.66% | -0.92 18.51% | -1.48 60.67% | -0.52 64.58% | -1.10 110.02% | -0.81 26.23% | |
sales general and administrative to revenue | 5.69 - | 18.14 219.03% | 13.40 26.13% | 9.96 25.63% | 54.13 443.17% | |||||
shareholders equity per share | -2.16 - | -2.94 36.39% | -3.68 25.00% | 1.27 134.55% | 0.98 22.83% | 0.36 63.12% | 0.86 138.59% | 0.41 52.75% | 0.36 12.25% | |
stock based compensation to revenue | 2.47 - | 6.28 154.82% | 2.47 60.72% | 3.26 32.03% | 16.77 414.50% | |||||
tangible asset value | -26.34M - | -25.90M 1.67% | -32.21M 24.37% | 9.46M 129.38% | 11.31M 19.54% | 6.06M 46.44% | 22.57M 272.36% | 11.75M 47.91% | 10.39M 11.64% | |
tangible book value per share | -2.21 - | -3.02 36.45% | -3.76 24.37% | 1.19 131.67% | 0.93 21.71% | 0.33 64.67% | 0.86 162.41% | 0.41 52.75% | 0.36 12.25% | |
working capital | 1.10M - | -5.11M 566.15% | 10.40M 303.50% | 10.68M 2.70% | 11.04M 3.43% | 5.84M 47.16% | 22.17M 279.85% | 11.51M 48.09% | 10.17M 11.66% |
All numbers in USD (except ratios and percentages)